Computational + Experimental Discovery
AI Drug Discovery Services
Computational Drug Discovery + Wet-Lab Validation
CycloGen combines AI-powered computational drug discovery with wet-lab capabilities delivered through our CRO partner network. Start with a biological target and build a discovery program combining structural intelligence, therapeutic design, computational candidate prioritization and experimental validation.
Integrated Drug Discovery
Computational Discovery Meets Experimental Science
A computational candidate remains a hypothesis until experimental evidence supports it. CycloGen connects AI-assisted discovery with experimental capabilities available through our CRO network, creating a coordinated path from target analysis and therapeutic design to laboratory investigation.
Instead of assembling disconnected computational tools and experimental vendors independently, biotechnology teams can build a coordinated computational-to-experimental discovery program.
One Discovery Program. Computational Design + Experimental Validation.
Choose the Discovery Program That Fits Your Science
AI + CRO Discovery Bundles
Build the Experimental Program Around the Science
Protein Discovery
CycloGen AI + Protein Design + CRO Protein Services
Target → Computational Design → Structural Assessment → Candidate Prioritization → Gene Synthesis → Protein Expression → Purification → Characterization
Applications: Nanobody discovery, Antibody discovery, Mini-binder discovery, Protein therapeutic design
Structural Biology
CycloGen Structural Intelligence + CRO Structural Services
Structure → Computational Analysis → Interaction Hypothesis → Candidate Selection → CRO Structural/Biophysical Study → Evidence
AI-Assisted Drug Discovery
CycloGen AI + Computational Screening + CRO Validation
Target → Structure → Design → Computational Screening → Candidate Prioritization → CRO Experiments → Results
CRO Partner Network
Computational Discovery. Experimental Reach.
CycloGen works with CRO partners to connect computational drug discovery with specialized experimental capabilities. Our CRO relationships include capabilities in major biotechnology hubs, allowing appropriate experimental services to be integrated with CycloGen computational discovery programs.
Cambridge
United Kingdom
Experimental and protein-service partner capabilities
Boston
United States
Biotechnology and experimental partner capabilities
Built for Emerging Biotech
Big Discovery Capability Without Building Everything In-House
Emerging biotechnology companies can have exceptional biology, proprietary targets and valuable therapeutic hypotheses without the infrastructure of a large pharmaceutical organization. Building computational infrastructure, recruiting specialized AI teams, establishing protein-production capabilities and coordinating multiple experimental providers can consume substantial time and capital.
CycloGen provides another path.
Connect Computational Design With Experimental Evidence
The objective is not simply to generate more molecules or protein sequences. It is to reduce a large design space to experimentally testable candidates, measure what happens in the laboratory, and use that evidence to inform subsequent discovery decisions.
Keep Computational Discovery Closer to Your IP
Private computational discovery does not require every intermediate computational artifact to become part of an external experimental workflow. The information required for a particular experiment can be transferred according to the customer's program, confidentiality requirements and CRO agreements.
From Scientific Question to Discovery Program
Discuss the Target
Understand the biology, therapeutic modality and scientific question.
Define the Program
Select appropriate CycloGen workflows and candidate evaluation strategy.
Design & Prioritize
Generate and computationally evaluate candidate designs.
Experiment
Move selected candidates into appropriately scoped CRO experimental program.
Learn & Iterate
Use experimental evidence to inform subsequent scientific decisions.
Frequently Asked Questions
What are AI drug discovery services?
+Can AI drug discovery be combined with wet-lab validation?
+Does CycloGen provide protein design services?
+Can CycloGen AI run on-premise?
+Does CycloGen operate the wet lab?
+Who owns the therapeutic IP?
+Start With the Science
Bring Us a Target. Build the Right Discovery Program Around It.
Whether you need private computational infrastructure, therapeutic design, candidate prioritization, wet-lab validation or an integrated AI + CRO discovery program, CycloGen can structure the engagement around the scientific objective.